MCAT and breast cancer: Missense variants A8860G in the MT-ATP6 gene and, C14766T and A15326G in the MT-CYB gene which had a prevalence of 93% or more among our patients and controls were seen at a 100% prevalence in a cohort of Malaysian breast cancer patients comprising of women of Chinese, Malay and Indian ethnicities [58].